PHAEOHYPHOMYCOSIS

PHAEOHYPHOMYCOSIS was reported 479 times

PHAEOHYPHOMYCOSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Nucleoside Analog Antifungal [EPC] 9 0.0063
1 Selective T Cell Costimulation Blocker [EPC] 13 0.0027
2 Antimetabolite Immunosuppressant [EPC] 45 0.0021
3 Dihydrofolate Reductase Inhibitor Antimalarial [EPC] 2 0.0016
4 Lipid-based Polyene Antifungal [EPC] 15 0.0012
5 Allylamine Antifungal [EPC] 5 0.0007
6 Azole Antifungal [EPC] 103 0.0007
7 CD52-directed Cytolytic Antibody [EPC] 12 0.0006
8 Echinocandin Antifungal [EPC] 5 0.0006
9 Sphingosine 1-phosphate Receptor Modulator [EPC] 8 0.0006
10 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 12 0.0005
11 Sulfonamide Antibacterial [EPC] 2 0.0005
12 Complement 5a Receptor Antagonist [EPC] 3 0.0004
13 Polyene Antifungal [EPC] 17 0.0004
14 Purine Antimetabolite [EPC] 39 0.0004
15 Corticosteroid [EPC] 407 0.0003
16 beta Lactamase Inhibitor [EPC] 1 0.0002
17 Asparagine-specific Enzyme [EPC] 3 0.0002
18 Oxazolidinone Antibacterial [EPC] 6 0.0002
19 Penem Antibacterial [EPC] 6 0.0002
20 CD38-directed Cytolytic Antibody [EPC] 1 0.0002
21 Calcineurin Inhibitor Immunosuppressant [EPC] 19 0.0001
22 Human Immunoglobulin G [EPC] 3 0.0001
23 Lipopeptide Antibacterial [EPC] 1 0.0001
24 Antimalarial [EPC] 1 0.0001
25 Antiprotozoal [EPC] 1 0.0001
26 Folate Analog Metabolic Inhibitor [EPC] 38 0.0001
27 Antimycobacterial [EPC] 2 0.0001
28 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 9 0.0001
29 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 9 0.0001
30 SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] 1 0.0001
31 Janus Kinase Inhibitor [EPC] 11 0.0001
32 Antirheumatic Agent [EPC] 7 0.0001
33 Glycopeptide Antibacterial [EPC] 4 0.0001
34 Nitroimidazole Antimicrobial [EPC] 4 0.0001
35 Selective T Cell Costimulation Modulator [EPC] 8 0.0001
36 CD20-directed Cytolytic Antibody [EPC] 18 0.0001
37 Orexin Receptor Antagonist [EPC] 1 0.0001
38 Fluoroquinolone Antibacterial [EPC] 5 0.0000
39 Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC] 2 0.0000
40 Kinase Inhibitor [EPC] 16 0.0000
41 Rifamycin Antibacterial [EPC] 1 0.0000
42 Estrogen Receptor Antagonist [EPC] 1 0.0000
43 Aminoglycoside Antibacterial [EPC] 1 0.0000
44 Factor Xa Inhibitor [EPC] 6 0.0000
45 Ester Local Anesthetic [EPC] 1 0.0000
46 Macrolide Antimicrobial [EPC] 1 0.0000
47 Central alpha-2 Adrenergic Agonist [EPC] 1 0.0000
48 Dihydropyridine Calcium Channel Blocker [EPC] 5 0.0000
49 Thiazide Diuretic [EPC] 3 0.0000
50 Tetracycline-class Drug [EPC] 1 0.0000
51 Non-Standardized Chemical Allergen [EPC] 1 0.0000
52 Alkylating Drug [EPC] 3 0.0000
53 Nucleoside Analog Antiviral [EPC] 1 0.0000
54 Amide Local Anesthetic [EPC] 1 0.0000
55 Nucleoside Metabolic Inhibitor [EPC] 3 0.0000
56 Partial Opioid Agonist [EPC] 1 0.0000
57 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
58 Programmed Death Receptor-1 Blocking Antibody [EPC] 1 0.0000
59 Antiarrhythmic [EPC] 1 0.0000
60 Interleukin-6 Receptor Antagonist [EPC] 1 0.0000
61 Tumor Necrosis Factor Blocker [EPC] 7 0.0000
62 Microtubule Inhibitor [EPC] 1 0.0000
63 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
64 Anti-epileptic Agent [EPC] 1 0.0000
65 Thalidomide Analog [EPC] 2 0.0000
66 Opioid Agonist [EPC] 1 0.0000
67 Platinum-based Drug [EPC] 1 0.0000
68 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
69 Insulin Analog [EPC] 1 0.0000
70 Atypical Antipsychotic [EPC] 1 0.0000
71 Proton Pump Inhibitor [EPC] 1 0.0000
72 Benzodiazepine [EPC] 1 0.0000